Keywords: Pfizer, Tofacitinib, Rheumatoid arthritis, USA, FDA advisory committee

FDA advisory backs Pfizer's tofacitinib for RA

Article | 10 May 2012

Print This

The US Food and Drug Administration’s Arthritis Advisory Committee yesterday voted eight to two to recommend approval of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in